Stankovikj, Svetlana
Full Name
Stankovikj, Svetlana
Main Affiliation
Email
svetlana.stankovikj@medf.ukim.edu.mk
Loading...
2
0
5
0
false
Loading...
3
0
5
0
false
Type
Fulltext
Results 1-4 of 4 (Search time: 0.003 seconds).
| Preview | Title | Author(s) | Issue Date | Type | |
|---|---|---|---|---|---|
| 1 | Efficasy, safety and pharmacokinetic profiles of a plasma-derived VWF/FVIII concentrate (Voncento) in subjects with hemophilia A (SWIFT-HA study) | Aleksander Skotnicki; Toshko J.Lissitckov; Vasily Mamonov; Evgeny Buevich; Kazimerz Kuliczkowski; Stefcho Goranov; Janusz Kloczko; Anna Klukowska; Svetlana Stankovic ; Liana Gercheva; Tatiana Chernova; Andrzej Hellmann; Anna Dmoszynska; Krystyana Zawilska; Alex VeldmanChristine Joch; Wilfried Seifert | 2016 | Article | |
| 2 | Efficasy, safety, and pharmacokinetics results of a phase II, double-blinded, randomized, cross-over study with Biostate in subjects with hemophilia A (the SWIFT-HA Study) | A.Skotnicki; Toshko J Lissitchkov; Vasily Mamonov; Evgeny Buevich; Kazimierz Kuliczkowski; Stefcho Goranov; Janusz Kłoczko; Anna Klukowska; Svetlana Stankovic ; Liana Gercheva; Tatiana Chernova; Andrzej Hellmann; Anna Dmoszyńska; Krystyna Zawilska; Alex Veldman; Christine Joch; Wilfried Seifert | 2012 | Proceeding article | |
| 3 |  | Efficasy, safety, and pharmacokinetics results of a phase II/III, multicentre, double-blinded, randomized, cross-over study with a plasma-derived von Wilebrand Factor (WVF)/factor VIII (FVIII) concentrate (Voncento) in subjects with hemophilia A (the SWIFT-HA Study) | A. Klukowska; A. Skotnicki; T. Lissitchkov; V. Mamonov; E. Buevich; K. Kuliczkowski; S. Goranov; J. Kolczko; S. Stankovic ; W. Seifert | 2014 | Proceeding article |
| 4 |  | Greater efficacy and less product consumption in early treatment of iliopsoas hemorrhage in patient with hemophilia and high titer inhibitor | Stankovic, S. | May-2013 | Proceeding article |